Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Hematologic Malignancy · Bone Marrow Transplant Rejection · Acute Myeloid Leukemia (AML) · Myelodysplastic Syndromes (MDS) · Acute Lymphoblastic Leukemia (ALL), Adult · Multiple Myeloma · Aplastic Anemia · Lymphoma · Non Hodgkin Lymphoma · Hodgkin Lymphoma · Chronic Myeloid Leukemia · Myelofibrosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Study leads
Christian B Gocke, MD, PhD
Principal Investigator
Johns Hopkins University